🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, placebo-controlled, Phase 2b study to evaluate the ef...
Status
Completed
Location
Investigational site 1
Start Date
2023-05-30
Trial ID
NCT05736107
Treatments Being Tested
This Phase 2 study will be an open-label and randomized study to assess the...
Status
Completed
Location
Karen L. Herbst, MD, PC
Start Date
2022-10-03
Trial ID
NCT05387733
Treatments Being Tested
The Stage 1 of this phase 2 study is an open-label single ascending dose (S...
Status
Completed
Location
Investigational Site
Start Date
2020-12-09
Trial ID
NCT04575467
Treatments Being Tested
This Phase 2 study will be an open-label and single course study to assess ...
Status
Completed
Location
DermResearch Inc
Start Date
2022-02-11
Trial ID
NCT05234736
Treatments Being Tested
The Phase 2a component of the study will be a randomized, open-label, paral...
Status
Completed
Location
Investigational site
Start Date
2020-02-03
Trial ID
NCT04698642
Treatments Being Tested
The Stage 2 of this phase 2 study will be a randomized, single-blind, place...
Status
Completed
Location
Investigational site 1
Start Date
2022-02-14
Trial ID
NCT04897412
Treatments Being Tested
The Stage 1 of this phase 2 study is an open-label single ascending dose (S...
Status
Completed
Location
Investigational Site 1
Start Date
2023-01-09
Trial ID
NCT05632926
Treatments Being Tested
A phase 2b, randomized, placebo-controlled study with long-term re-treatmen...
Status
Recruiting
Location
Investigational Site 1
Start Date
2026-06
Trial ID
NCT07608770
Treatments Being Tested
This is a single-blind, placebo-controlled, randomized phase 2 study to eva...
Status
Active Not Recruiting
Location
Investigator Site
Start Date
2024-11-27
Trial ID
NCT06303570
Treatments Being Tested
The Stage 2 of this phase 2 study is an open-label, single-arm study to ass...
Status
Completed
Location
Investigational Site 6
Start Date
2023-05-10
Trial ID
NCT05836779
Treatments Being Tested